In TRA-2P Study, Adding Merck’s Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovascular Events

In CategoryCardiovascular Health, Drugs and Drug Companies
ByRuss Bianchi

Drugs KILL, Plants CURE.

Drink Life In!®

~ Uncle Russ

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck’s investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

In TRA-2P Study, Adding Merck’s Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovascular Events

Share

High fructose consumption by adolescents may put them at cardiovascular risk

In CategoryArtificial Sweeteners, Baby/Children/Teen Health, Cardiovascular Health, HFCS & Sugars
ByRuss Bianchi

HFCS is the leading cause, at any consumption, in anyone, at any level, of cardiovascular disease, diabetes, depression, inflammation, cancers, birth defects, and obesity.

~ Uncle Russ

Evidence of cardiovascular disease and diabetes risk is present in the blood of adolescents who consume a lot of fructose, a scenario that worsens in the face of excess belly fat, researchers report.

High fructose consumption by adolescents may put them at cardiovascular risk

Share

WARFARIN Study at Colorado Heart & Vascular to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin

In CategoryCardiovascular Health, Drugs and Drug Companies
ByRuss Bianchi

What do you not GET about blood thinners being RAT POISON and destroying your liver and harming you?!  Hello?

~ Uncle Russ

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

WARFARIN Study at Colorado Heart & Vascular to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin

Share

Diet Soda May Raise Odds of Vascular Events; Salt Linked to Stroke Risk

In CategoryBeverages, Cardiovascular Health
ByRuss Bianchi

I TOLD YOU SO!

GOT ZIJA®?!

~ Uncle Russ

ScienceDaily (Feb. 10, 2011) — Even if you drink diet soda — instead of the sugar variety — you could still have a much higher risk of vascular events compared to those who don’t drink soda, according to research presented at the American Stroke Association’s International Stroke Conference 2011.

Diet Soda May Raise Odds of Vascular Events; Salt Linked to Stroke Risk

Share

Heart Patients With Anxiety Disorder Experience More Cardiovascular Events, Deaths

In CategoryCardiovascular Health, Emotional Health
ByRuss Bianchi

Like I have told you before, if it is a disorder, condition or syndrome, it is Big Pharma trying to hawk you another useless, dangerous and expensive drug.

Anxiety?  Try D-3, buffered B-3 for the heart and Zija® along with a healthy diet described at ITEMS TO STAY AWAY FROM under my highlighted suggestion on this web site for optimum wellness.

~ Uncle Russ

ScienceDaily (July 6, 2010) — Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Heart Patients With Anxiety Disorder Experience More Cardiovascular Events, Deaths

Share

Study finds post-transplant patients off steroids have fewer cardiovascular events

In CategoryCardiovascular Health, Drugs and Drug Companies, Other Human Health Conditions
ByRuss Bianchi

Steroids harm, hinder and kill, do not use them.

~ Uncle Russ

Post-transplant patients who have been removed from a corticosteroid regimen have fewer cardiovascular events than those patients on steroids, increasing their graft survival rates and reducing early mortality, according to study results being presented this week by University of Cincinnati (UC) transplantation researchers.

Study finds post-transplant patients off steroids have fewer cardiovascular events

Share